| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.04 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |